Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 5, 2011, Pages 519-527

  Hussain, Arif ^a   Brahmbhatt, Kruti ^a   Priyani, Anita ^a   Ahmed, Musthaq ^a   Rizvi, Tahir A ^b   Sharma, Chhavi ^a  

^a Manipal University   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Bcl 2; chemoprevention; COX 2; eugenol; gemcitabine; IL 1

Indexed keywords

CYCLOOXYGENASE 2; EUGENOL; GEMCITABINE; INTERLEUKIN 1BETA; PROTEIN BCL 2;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRUCTURE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DRUG SYNERGISM; EUGENOL; FEMALE; HELA CELLS; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 80054714275     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2010.0925     Document Type: Article

References (67)

1. Merle P, Morvan D, Caillaud D, et al. Chemotherapy-induced bystander effect in response to several chlor-oethylnitrosoureas: An origin independent of DNA damage? Anticancer Res 2008;28:21.
2. Di X, Bright AT, Bellott R, et al. A chemotherapy-associated senescence bystander effect in breast cancer cells. Cancer Biol Ther 2008;7:864.
3. Abdullah H, Lope Pihie AH, Hohmann J, et al. A natural compound from Hydnophytum formicarium induces apo-ptosis of MCF-7 cells via up-regulation of Bax. Cancer Cell Int 2010;10:14.
4. Stoner GD, Morse MA, Kelloff GJ. Perspectives in cancer chemoprevention. Environ Health Perspect 1997;105:945.
5. Hussain A, Sasidharan S, Ahmed T, et al. Clove (Syzygium aromaticum) extract potentiates gemcitabine cytotoxic effect on human cervical cancer cell line. Int J Cancer Res 2009; 5:95.
6. Fujisawa S, Atsumi T, Kadoma Y, et al. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 2002;177:39.
7. Rasheed A, Laekeman G, Totte J, et al. Eugenol and pros-taglandin biosynthesis. New Engl J Med 1984;310:50.
8. Kaur G, Athar M, Alam SM. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Life Sci 2003;73:337.
9. Park BS, Song YS, Yee SB. Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis 2005;10:193.
10. Okada N, Hirata A, Murakami Y, et al. Induction of cyto-toxicity and apoptosis and inhibition of cyclooxigenase-2 gene expression by eugenol-related compounds. Anticancer Res 2005;25:3263.
11. Hemaiswarya S, Doble M. Synergistic interaction of eugenol with antibiotics against gram negative bacteria. Phytome-dicine 2009;16:997.
12. Pal D, Banerjee S, Mukherjee S, et al. Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: Downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway. J Dermatol Sci 2010; 59:31.
13. Sukumaran K, Unnikrishnan MC, Kuttan R. Inhibition of tumour promotion in mice by eugenol. Indian J Physiol Pharmacol 1994;38:306.
14. Ghosh R, Nadiminty N, Fitzpatrick JE, et al. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 2005; 280:5812.
15. Manikandan P, Murugan RS, Priyadarsini RV, et al. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 2010;86:936.
16. Huss U, Ringbom T, Perera P, et al. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 2002;65:1517.
17. Yoo CB, Han KT, Cho KS. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer lett 2005;225:41.
18. Pisano M, Pagnan G, Loi M. Antiproliferative and pro-apoptotic activity of Eugenol-related biphenyls on malignant melanoma cells. Mol Cancer 2007;6:8.
19. Arafa E, Zhu Q, Barakat BM, et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res 2009;69:8910.
20. Banerjee S, Wang Z, Kong D, et al. 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res 2009;69:5592.
21. Hussain A, Priyani A, Sadrieh L, et al. Concurrent sulfor-aphane and eugenol induces differential effects on human cervical cancer cells. Integr Cancer Ther 2011 DOI: 10.1177/1534735411400313.
22. Sharma R, Shukla NK, Mathur M, et al. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology 2004; 67:300.
23. Wang AG, Kim SU, Lee SH, et al. Histone deacetylase 1 contributes to cell cycle and apoptosis. Biol Pharm Bull 2005; 28:1966.
24. Bondesen BA, Mills ST, Kegley KM, et al. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004; 287:475.
25. Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217.
26. Candelaria M, Garcia-Arias A, Cetina L, et al. Radio-sensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006;8:15.
27. Yip-Schneider MT, Wu H, Ralstin M. Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo. Mol Cancer Ther 2007;6:1736.
28. Dima SO, Iacob S, Botea F. Multimodal treatment of hepa-tocellular carcinoma: An eastern European experience. He-patogastroenterology 2009;56:1696.
29. Takeshima T, Chamoto K, Wakita D. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: Its potentiation by combination with Th1 cell therapy. Cancer Res 2010;70:2697.
30. You M, Savaraj N, Wangpaichitr M. The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines. Biochem Biophys Res Commun 2010; 394:760.
31. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 2006;66:3347.
32. Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, Ben-Yosef R. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 2007;25:411.
33. Park J, Ayyappan V, Bae EK. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol 2008; 2:317.
34. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397.
35. Davidson P, Touger-Decker R. Chemopreventive role of fruits and vegetables in oropharyngeal cancer. Nutr Clin Pract 2009;24:250.
36. Moon DO, Kang SH, Kim KC, et al. Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett 2010;295:260.
37. Ramos S. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nut Food Res 2008;52:507.
38. Kim GC, Choi DS, Lim JS, et al. Caspases-dependent apo-ptosis in human melanoma cell by Eugenol. Korean J Anat 2006;39:245.
39. Fischera IU, Dengler HJ. Sensitive high-performance liquid chromatographic assay for the determination of eugenol in body fluids. J Chromatogr 1990;525:369.
40. Russo H, Carrasco A, Espinoza LC. Eugenol and its synthetic analogues inhibit cell growth of human cancer cells. J Braz Chem Soc 2008;19:543.
41. Girdhani S, Bhosle SM, Thulsidas SA, et al. Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Cancer Res Ther 2005;1:129.
42. Baell J, Huang DCS. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem Pharmacol 2002;64:851.
43. Young SC, Wang CJ, Hsu JD, et al. Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract. Arch Toxicol 2006; 80:319.
44. Mashima T, Tsuruo T. Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist Updat 2005; 8:339.
45. Fleischer A, Ghadiri A, Dessauge F, et al. Modulating apo-ptosis as a target for effective therapy. Mol Immunol 2006; 43:1065.
46. Yu R, Mandlekar S, Harvey KJ, et al. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity1. Cancer Res 1998;58:402.
47. Bold RJ, Chandra J, McConkey DJ. Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. Ann Surg Oncol 1999;6:279.
48. Hernández P, Olivera P, Duenas-Gonzalez A, et al. Gemci-tabine activity in cervical cancer cell lines. Cancer Che-mother Pharmacol 2001;48:488.
49. Harikumar KB, Kunnumakkara AB, Sethi G, et al. Res-veratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 2010; 127:257.
50. Pellecchia M, Reed JC. Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: New avenues for cancer chemoprevention and chemotherapy. Curr Pharm Des 2004;10:1387.
51. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992;11:121.
52. Fisher TC, Milner AE, Gregory CD, et al. Bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance pathways thymidylate stress is independent of classical resistance pathways. Cancer Res 1993;53:3321.
53. Giardiello FM, Offerhaus GJ, DuBois RN. The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer 1995;31:1071.
54. Sano H, Hla T, Maier JAM, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and strcptococcal cell wall arthritis. J Clin Invest 1992; 89:97.
55. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107:1183.
56. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493.
57. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003;24:96.
58. DuBois RN, Smalley WE. Cyclooxygenase, NSAIDs, and colorectal cancer. J Gastroenterol 1996;31:898.
59. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expressions in colon cells by the che-mopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999;18:6013.
60. Subbaramaiah K, Chung WJ, Michaluart P, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875.
61. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095.
62. Chen Z, Malhotra PS, Thomas GR. Expression of proin-flammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5:1369.
63. Gemma A, Takenaka K, Hosoya Y. Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur J Cancer 2001;37:1554.
64. Apte RN, Krelin Y, Song X. Effects of micro-environment-and malignant cell-derived interleukin-in carcinogenesis, tumor invasiveness and tumor-host interactions. Eur J Cancer 2006;42:751.
65. Elaraj DM, Weinreich DM, Varghese S. The role of inter-leukin 1 in growth and metastasis of human cancer xeno-grafts. Clin Cancer Res 2006;12:1088.
66. Estrov Z, Shishodia S, Faderl S. Resveratrol blocks interleukin-1beta- induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987.
67. Moon Y, Glasgow WC, Eling TE. Curcumin suppresses interleukin 1b-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharma Exp Ther 2005; 315:788.